First Time Loading...

Jasper Therapeutics Inc
NASDAQ:JSPR

Watchlist Manager
Jasper Therapeutics Inc Logo
Jasper Therapeutics Inc
NASDAQ:JSPR
Watchlist
Price: 23.95 USD -2.32% Market Closed
Updated: Jun 11, 2024

Jasper Therapeutics Inc
Total Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jasper Therapeutics Inc
Total Assets Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
Jasper Therapeutics Inc
NASDAQ:JSPR
Total Assets
$94.9m
CAGR 3-Years
60%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Assets
$148.9B
CAGR 3-Years
0%
CAGR 5-Years
21%
CAGR 10-Years
18%
Gilead Sciences Inc
NASDAQ:GILD
Total Assets
$56.3B
CAGR 3-Years
-6%
CAGR 5-Years
-2%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Total Assets
$93B
CAGR 3-Years
14%
CAGR 5-Years
8%
CAGR 10-Years
3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Assets
$23.9B
CAGR 3-Years
25%
CAGR 5-Years
30%
CAGR 10-Years
27%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Assets
$34.4B
CAGR 3-Years
25%
CAGR 5-Years
22%
CAGR 10-Years
27%

See Also

What is Jasper Therapeutics Inc's Total Assets?
Total Assets
94.9m USD

Based on the financial report for Dec 31, 2023, Jasper Therapeutics Inc's Total Assets amounts to 94.9m USD.

What is Jasper Therapeutics Inc's Total Assets growth rate?
Total Assets CAGR 3Y
60%

Over the last year, the Total Assets growth was 96%. The average annual Total Assets growth rates for Jasper Therapeutics Inc have been 60% over the past three years .